<VariationArchive VariationID="29669" VariationName="NM_001289808.2(CRYAB):c.60del (p.Ser21fs)" VariationType="Deletion" Accession="VCV000029669" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-04-06" DateCreated="2013-04-04" MostRecentSubmission="2022-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="38624" VariationID="29669">
      <GeneList>
        <Gene Symbol="CRYAB" FullName="crystallin alpha B" GeneID="1410" HGNC_ID="HGNC:2389" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q23.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="111908564" stop="111923740" display_start="111908564" display_stop="111923740" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="111779349" stop="111782472" display_start="111779349" display_stop="111782472" Strand="-" />
          </Location>
          <OMIM>123590</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001289808.2(CRYAB):c.60del (p.Ser21fs)</Name>
      <CanonicalSPDI>NC_000011.10:111911664:GGGGG:GGGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q23.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="111911665" stop="111911665" display_start="111911665" display_stop="111911665" variantLength="1" positionVCF="111911664" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="111782389" stop="111782389" display_start="111782389" display_stop="111782389" variantLength="1" positionVCF="111782388" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>S21fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.111911669del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.111911669del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.111782393del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.111782393del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009824.3" sequenceAccession="NG_009824" sequenceVersion="3" change="g.17058del">
            <Expression>NG_009824.3:g.17058del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033080.2" sequenceAccession="NG_033080" sequenceVersion="2" change="g.3934del">
            <Expression>NG_033080.2:g.3934del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001289807.1" sequenceAccession="NM_001289807" sequenceVersion="1" change="c.60del">
            <Expression>NM_001289807.1:c.60del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001276736.1" sequenceAccession="NP_001276736" sequenceVersion="1" change="p.Ser21fs">
            <Expression>NP_001276736.1:p.Ser21fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001289808.2" sequenceAccession="NM_001289808" sequenceVersion="2" change="c.60del" MANESelect="true">
            <Expression>NM_001289808.2:c.60del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001276737.1" sequenceAccession="NP_001276737" sequenceVersion="1" change="p.Ser21fs">
            <Expression>NP_001276737.1:p.Ser21fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368245.1" sequenceAccession="NM_001368245" sequenceVersion="1" change="c.60del">
            <Expression>NM_001368245.1:c.60del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355174.1" sequenceAccession="NP_001355174" sequenceVersion="1" change="p.Ser21fs">
            <Expression>NP_001355174.1:p.Ser21fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001885.3" sequenceAccession="NM_001885" sequenceVersion="3" change="c.60del">
            <Expression>NM_001885.3:c.60del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001876.1" sequenceAccession="NP_001876" sequenceVersion="1" change="p.Ser21fs">
            <Expression>NP_001876.1:p.Ser21fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_407" sequenceAccession="LRG_407">
            <Expression>LRG_407:g.17058del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_407t2" sequenceAccession="LRG_407t2">
            <Expression>LRG_407t2:c.60del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_407p2" sequenceAccession="LRG_407p2" change="p.Ser21fs">
            <Expression>LRG_407p2:p.Ser21fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_407t1" sequenceAccession="LRG_407t1">
            <Expression>LRG_407t1:c.60del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_407p1" sequenceAccession="LRG_407p1" change="p.Ser21fs">
            <Expression>LRG_407p1:p.Ser21fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA344702" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="123590.0005" DB="OMIM" />
        <XRef Type="rs" ID="281865141" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001289808.2(CRYAB):c.60del (p.Ser21fs) AND Myofibrillar myopathy 2" Accession="RCV000043523" Version="30">
        <ClassifiedConditionList TraitSetID="5581">
          <ClassifiedCondition DB="MedGen" ID="C1837317">Myofibrillar myopathy 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-05-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-05-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2022-10-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21337604</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8000975</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301672</ID>
          <ID Source="BookShelf">NBK1499</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5581" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="156" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alpha-B crystallinopathy</ElementValue>
                <XRef ID="MYOPATHY%2C+MYOFIBRILLAR%2C+FATAL+INFANTILE+HYPERTONIC%2C+ALPHA-B+CRYSTALLIN-RELATED/8958" DB="Genetic Alliance" />
                <XRef ID="Alpha-B+crystallinopathy/7669" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Myofibrillar myopathy 2</ElementValue>
                <XRef ID="MONDO:0012130" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYOPATHY, DESMIN-RELATED, ASSOCIATED WITH MUTATION IN THE CRYAB GENE</ElementValue>
                <XRef Type="MIM" ID="608810" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYOPATHY, MYOFIBRILLAR, ALPHA-B CRYSTALLIN-RELATED</ElementValue>
                <XRef Type="MIM" ID="608810" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYOPATHY, MYOFIBRILLAR, WITH OR WITHOUT CATARACT AND/OR CARDIOMYOPATHY</ElementValue>
                <XRef Type="MIM" ID="608810" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MFM2</ElementValue>
                <XRef Type="MIM" ID="608810" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17651" />
                <XRef ID="17651" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="280553" DB="Orphanet" />
              <XRef ID="399058" DB="Orphanet" />
              <XRef ID="C1837317" DB="MedGen" />
              <XRef ID="MONDO:0012130" DB="MONDO" />
              <XRef Type="MIM" ID="608810" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="49063" SubmissionDate="2016-09-15" DateLastUpdated="2016-09-18" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="123590.0005_MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED" title="CRYAB, 1-BP DEL, 60C_MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED" />
        <ClinVarAccession Accession="SCV000043807" DateUpdated="2016-09-18" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 8 patients with fatal infantile hypertonic myofibrillar myopathy (613869), including 3 reported by Lacson et al. (1994), Del Bigio et al. (2011) identified the same homozygous 1-bp deletion in the CRYAB gene (123590.0005), resulting in a ser21-to-ala (S21A) change and a stop codon after 23 missense residues. All patients were Canadian aboriginals of Cree descent, consistent with a founder effect. The phenotype was characterized by onset in the first weeks of life of rapidly progressive muscular rigidity of the trunk and limbs associated with increasing respiratory difficulty resulting in death before age 3 years. Muscle biopsies showed dystrophic changes, endomysial fibrosis, eosinophilic deposits, and Z-band streaming. Immunohistochemistry using an antibody against the full-length CRYAB protein showed absence of staining, but an antibody against the first 10 residues of the protein showed some residual staining. Heterozygous parents were unaffected, including 1 mother with mild myopathic symptoms but normal CK levels. Del Bigio et al. (2011) noted that late-onset myofibrillar myopathy (608810) is typically seen in heterozygous individuals; however, in this disease, the parental phenotype may be rescued by limited expression of the 44-amino acid truncated nonfunctional gene product. Del Bigio et al. (2011) postulated that a disruption of CRYAB interaction with titin (TTN; 188840) may contribute to reduced muscle elasticity.</Attribute>
              <Citation>
                <ID Source="PubMed">8000975</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">21337604</ID>
              </Citation>
              <XRef DB="OMIM" ID="613869" Type="MIM" />
              <XRef DB="OMIM" ID="608810" Type="MIM" />
              <XRef DB="OMIM" ID="188840" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CRYAB" />
          </GeneList>
          <Name>CRYAB, 1-BP DEL, 60C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 60C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="123590.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="92289" SubmissionDate="2013-01-08" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_001885.1:c.60delC_NBK1499" title="NM_001885.1:c.60delC and Myofibrillar Myopathy" />
        <ClinVarAccession Accession="SCV000055819" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">20301672</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="BookShelf">NBK1499</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="281865141" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001885.1:c.60delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1837317" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="49063" TraitType="Disease" MappingType="Name" MappingValue="MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED" MappingRef="Preferred">
        <MedGen CUI="C5190691" Name="Fatal infantile hypertonic myofibrillar myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="92289" TraitType="Disease" MappingType="XRef" MappingValue="C1837317" MappingRef="MedGen">
        <MedGen CUI="C1837317" Name="Myofibrillar myopathy 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>